| # | Drug | Count |
|---|---|---|
| 0 | RESMETIROM | 68 |
| 1 | ORAL SEMAGLUTIDE | 32 |
| 2 | METFORMIN | 31 |
| 3 | ASPIRIN | 21 |
| 4 | ASPIRIN 325 MG | 21 |
| 5 | ASPIRIN 81 MG | 21 |
| 6 | METFORMIN ER 500 MG | 21 |
| 7 | METFORMIN ER 750 MG | 21 |
| 8 | PREDNISONE | 21 |
| 9 | ALBUTEROL SULFATE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RESMETIROM | 68 | 0.0296 |
| 1 | INFLIXIMAB-AXXQ | 2 | 0.0017 |
| 2 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| 3 | BELATACEPT | 5 | 0.0011 |
| 4 | ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) | 2 | 0.0009 |
| 5 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 5 | 0.0005 |
| 6 | ERGOCALCIFEROL | 16 | 0.0005 |
| 7 | ORAL SEMAGLUTIDE | 32 | 0.0004 |
| 8 | RIFAXIMIN | 8 | 0.0004 |
| 9 | ICOSAPENT ETHYL | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Thyroid Hormone Receptor beta Agonist [EPC] | 68 |
| 1 | GLP-1 Receptor Agonist [EPC] | 46 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 34 |
| 3 | Corticosteroid [EPC] | 27 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 21 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 17 |
| 6 | Proton Pump Inhibitor [EPC] | 17 |
| 7 | Provitamin D2 Compound [EPC] | 16 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 15 |
| 9 | Benzodiazepine [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Receptor beta Agonist [EPC] | 68 | 0.0296 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 2 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 3 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 5 | 0.0011 |
| 5 | Leptin Analog [EPC] | 1 | 0.0008 |
| 6 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 7 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 8 | Rifamycin Antibacterial [EPC] | 9 | 0.0002 |
| 9 | Antiparasitic [EPC] | 1 | 0.0002 |